Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Changes of neurocognitive status in patients with the first-episode psychosis after 18 months of treatment–A prospective cohort study (CROSBI ID 299617)

Prilog u časopisu | izvorni znanstveni rad

Bošnjak Kuharić, Dina ; Makarić, Porin ; Kekin, Ivana ; Rossini Gajšak, Linda ; Živković, Maja ; Ostojić, Draženka ; Silić, Ante ; Bajić, Žarko ; Lukačević Lovrenčić, Iva ; Beezhold, Julijan et al. Changes of neurocognitive status in patients with the first-episode psychosis after 18 months of treatment–A prospective cohort study // Psychiatry research, 304 (2021), 114131, 8. doi: 10.1016/j.psychres.2021.114131

Podaci o odgovornosti

Bošnjak Kuharić, Dina ; Makarić, Porin ; Kekin, Ivana ; Rossini Gajšak, Linda ; Živković, Maja ; Ostojić, Draženka ; Silić, Ante ; Bajić, Žarko ; Lukačević Lovrenčić, Iva ; Beezhold, Julijan ; Rojnić Kuzman, Martina

engleski

Changes of neurocognitive status in patients with the first-episode psychosis after 18 months of treatment–A prospective cohort study

Neurocognitive symptoms exert the most influence on treatment outcomes over the course of schizophrenia, starting from the first-episode of psychosis (FEP) onwards. Our aim was to analyze the neurocognitive status of FEP compared to healthy controls (HC), and its change after 18 months of treatment. We performed a study in a sample of 159 patients with FEP and 100 HC. We followed the patients up for 18 months after initial assessment with a battery of neurocognitive tests. We observed statistically significant improvement in the majority of neurocognitive tests after 18 months, but several tests of specific neurocognitive domains (verbal memory, language functions, executive functions) did not show significant differences between the two assessments. The results for the majority of tests obtained from patients with FEP after 18 months of treatment showed significant deterioration compared with HC. Although our study showed significant improvement of baseline neurocognitive deficits in FEP with treatment, this varied across domains and overall performance remained below that of HC. Thus, while it seems that treatment of FEP may help to delay or restore neurocognitive deterioration, it is unclear whether specific areas of neurocognitive deterioration (e.g. verbal domain) would benefit from more time or specific treatment approaches.

first-episode psychosis ; schizophrenia ; neurocognitive deficits ; neurocognitive symptoms ; follow-up

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

304

2021.

114131

8

objavljeno

0165-1781

1872-7123

10.1016/j.psychres.2021.114131

Povezanost rada

Kliničke medicinske znanosti

Poveznice
Indeksiranost